rna
interfer
rnai
evolutionarili
conserv
phenomenon
doublestrand
ds
rnamedi
mrna
degrad
lead
posttranscript
silenc
correspond
gene
first
report
rnai
emerg
sinc
becom
one
fascin
field
molecular
biolog
rnai
provid
import
insight
divers
rna
molecul
implic
mani
biolog
process
regul
development
gene
eukaryot
organ
furthermor
rnai
rapidli
develop
power
instrument
great
potenti
function
genom
therapeut
applic
silenc
normal
diseaserel
gene
function
date
use
rnai
geneticbas
therapi
wide
studi
especi
viral
infect
cancer
inherit
genet
disord
despit
mani
unansw
question
technolog
effici
appli
human
develop
novel
approach
vaccin
novel
deliveri
agent
certainli
one
major
goal
rnai
research
discov
year
ago
rna
interfer
rnai
alreadi
gain
access
almost
biomed
even
chemic
laboratori
techniqu
allow
suppress
gene
function
effect
way
rnai
specif
form
rna
silenc
induc
doublestrand
ds
rna
result
sequencespecif
cleavag
homolog
mrna
rnai
first
observ
nematod
caenorhabd
elegan
guo
kemphu
antisens
experi
howev
decis
discoveri
made
fire
mello
tri
explain
silenc
activ
sens
control
rna
found
guo
kemphu
experi
simultan
inject
sens
antisens
rna
strand
c
elegan
obtain
stronger
effect
silenc
homolog
mrna
antisens
rna
alon
led
conclus
dsrna
trigger
effici
silenc
mechan
exogen
dsrna
significantli
reduc
overal
level
target
mrna
investig
phenomenon
number
featur
discov
made
rnai
exit
new
tool
molecular
biolog
rnai
highli
select
mrna
degrad
exogen
ad
dsrna
share
sequenc
perfect
homolog
target
translat
protein
inhibit
specif
degrad
encod
mrna
transcript
gene
remain
unaffect
dsrna
homolog
intron
sequenc
promot
compris
dna
sequenc
show
effect
silenc
appear
take
place
posttranscript
level
substoichiometr
amount
dsrna
suffici
decreas
mrna
level
within
h
rnai
phenotyp
progress
system
distribut
differ
organ
varieti
organ
moreov
cultur
cell
transfect
dsrna
maintain
lossoffunct
phenotyp
nine
cell
divis
know
today
rnai
relat
wellknown
form
posttranscript
gene
silenc
ptg
recent
believ
occur
exclus
plant
drosophila
cosuppress
neurospora
crassa
quell
respons
retrovir
transpos
element
invas
trigger
cellular
defens
mechan
dsrna
occur
replic
element
never
tightli
regul
endogen
gene
intermedi
dsrna
recogn
degrad
moreov
rnai
machineri
presum
carri
numer
addit
function
evid
elimin
defect
mrna
degrad
gene
function
simultan
rnai
nonsensemedi
mrna
decay
nmd
rnai
assum
tightli
regul
protein
level
respons
variou
environment
stimuli
although
extent
mechan
employ
specif
cell
type
remain
estim
suggest
rnai
evolutionarili
conserv
among
eukaryot
occur
respons
presenc
dsrna
last
year
intens
molecular
biochem
studi
undertaken
identifi
character
particip
player
rnai
pathway
furthermor
research
develop
rnai
standard
tool
vivo
revers
genet
studi
mani
eukaryot
system
chapter
give
overview
discoveri
current
state
rnai
research
known
mechan
implic
function
genom
studi
design
therapeut
approach
diseas
soon
discoveri
rnai
question
mechan
aros
mani
laboratori
direct
research
toward
identif
protein
implic
rnai
pathway
molecular
biochem
character
even
though
rnai
pathway
still
fulli
understood
mani
main
player
alreadi
well
character
mani
follow
sure
near
futur
first
success
correl
rnai
long
known
rna
silenc
phenomena
cosuppress
quell
phenomena
refer
rna
silenc
inde
genet
studi
rnasilencingdefici
mutant
arabidopsi
n
crassa
c
elegan
reveal
sever
gene
conserv
throughout
three
phenomena
includ
member
helicas
famili
rnase
iiirel
nucleas
member
argonaut
famili
rnadepend
rna
polymeras
rdrp
among
first
protein
identifi
thoroughli
investig
dicer
member
rnase
iii
famili
discoveri
base
observ
dsrna
process
smaller
fragment
compris
length
nucleotid
nt
depend
organ
gener
small
dsrna
complementari
strand
silenc
gene
initi
observ
plant
undergo
transgeneor
virusinduc
posttranscript
gene
silenc
cosuppress
later
zamor
cowork
identifi
small
rna
speci
incub
drosophila
extract
long
dsrna
date
known
activ
dsrna
speci
rnai
pathway
refer
small
interf
rna
sirna
exhibit
characterist
featur
dsrna
fragment
origin
cleavag
long
exogen
dsrna
dsrnaspecif
rnase
iii
addit
alreadi
character
member
rnase
iii
famili
regular
canon
rnase
iii
drosha
local
nucleu
homolog
screen
genom
data
drosophila
reveal
new
candid
gene
rnase
iiilik
domain
among
candid
nucleas
amino
acid
predict
drosophila
sequenc
data
contain
two
rnase
iii
domain
dsrnabind
motif
dsrm
aminotermin
dexhdeah
rna
helicaseatpas
domain
socal
paz
domain
properti
character
member
ribonucleas
rnase
iii
famili
refer
abil
gener
equal
size
fragment
long
dsrna
enzym
call
dicer
catalysi
initi
step
rnai
pathway
recognit
degrad
dsrna
sirna
confirm
fig
although
organ
encod
one
human
mous
c
elegan
schizosaccharomyc
pomb
two
drosophilia
melanogast
homolog
plant
like
arabidopsi
encod
least
four
dicerlik
enzym
evolutionarili
conserv
paz
domain
assum
function
nucleicacidbind
motif
mean
multipl
parasit
element
prevent
integr
host
genom
inhibit
furthermor
dicer
play
domin
role
process
anoth
small
rna
speci
microrna
fig
mirna
also
resembl
length
nt
recent
identifi
eukaryot
organ
includ
plant
c
elegan
human
mirna
process
long
stem
loop
precursor
encod
evolutionarili
conserv
nonprotein
code
gene
heterogen
structur
shown
bona
fide
regul
gene
express
repress
transcript
like
rnase
iii
cleavag
product
sirna
mirna
bear
twonucleotid
overhang
end
structur
featur
indispens
capac
exhibit
silenc
activ
accord
structur
bacteri
rnaseiii
two
activ
center
embrac
cleft
accommod
dsrna
substrat
dicer
propos
function
antiparallel
dimer
dicer
contain
two
catalyt
domain
suggest
dimer
two
four
center
remain
activ
process
dsrna
sirna
appropri
size
anoth
work
model
propos
monomer
action
dicer
cleav
dsrna
transloc
enzym
along
substrat
process
would
requir
partial
unwind
dsrna
probabl
helicas
domain
energyconsum
step
drive
transloc
enzym
along
dsrna
atpdepend
manner
mode
action
might
occur
drosophila
invertebr
mammal
dicer
act
atpindepend
way
vivo
dicer
part
protein
complex
even
though
molecular
mechan
dicermedi
dsrna
cleavag
partial
unravel
still
fulli
clarifi
initi
step
connect
effector
step
dicer
directli
involv
cleavag
target
mrna
last
yr
sever
protein
identifi
seem
play
role
interact
partner
even
rnai
signal
transport
sirna
move
freeli
throughout
cytoplasm
ensur
specif
target
recognit
sirna
bound
dicerassoci
protein
thu
transfer
effector
complex
also
known
rnainduc
silenc
complex
risc
interact
might
occur
two
paz
domain
dicer
facilit
transfer
sirna
recent
discov
protein
harbor
tandem
dsrnabind
domain
drosophila
domain
requir
transfer
sirna
assur
stabil
dicer
cleavag
product
form
stabl
complex
nascent
sirna
serv
transfer
shuttl
sirna
dicer
risc
although
dicer
alon
suffici
cleav
dsrna
requir
bind
nascent
sirna
also
synthet
sirna
appear
newli
gener
symmetr
sirna
releas
complex
rather
retain
fix
orient
might
determin
guid
strand
target
cleavag
sirna
serv
templat
sequencespecif
cleavag
endogen
target
mrna
proven
identif
sirna
associ
risc
far
drosophila
risc
first
propos
approx
complex
bound
ribosom
cellfre
extract
closer
studi
identifi
multifunct
ribonucleotid
protein
complex
rnp
contain
deadbox
helicas
nucleas
seem
conserv
drosophila
c
elegan
mammal
although
overlap
complet
unwind
sirna
mediat
atpdepend
helicas
convert
risc
activ
form
risc
antisens
sirna
strand
remain
bound
risc
serv
guid
strand
recognit
target
mrna
target
bind
occur
via
convent
watsoncrick
basepair
perfect
homolog
promot
cleavag
nucleas
activ
risc
recent
studi
shown
antisens
rna
rang
nt
also
enter
rnai
pathway
albeit
less
effici
lack
inform
correct
strand
orient
sirna
sens
strand
may
enter
rnai
pathway
even
sirna
bound
transfer
risc
predetermin
orient
hand
separ
antisens
sens
strand
distinct
sirna
reveal
similar
intrins
efficaci
target
specif
mrna
show
differ
activ
hybrid
duplex
sirna
stabil
end
determin
strand
enter
risc
one
releas
degrad
end
start
less
stabl
au
basepair
prefer
begin
stabl
gc
suggest
risc
helicas
prefer
act
less
stabl
end
lead
preferenti
incorpor
respect
strand
risc
prefer
even
enhanc
g
u
wobbl
basepair
respect
end
statist
analysi
intern
thermodynam
stabil
hundr
synthet
sirna
recent
confirm
decreas
stabil
end
function
duplex
refer
antisens
strand
facilit
incorpor
antisens
strand
risc
thu
sens
strand
instabl
end
might
incorpor
risc
presum
lead
offtarget
effect
sirna
singl
strand
eventu
resid
risc
togeth
homolog
argonaut
protein
andor
contain
piwi
paz
domain
screen
argonaut
mutant
plant
c
elegan
n
crassa
establish
link
gene
famili
rnai
even
though
bind
affin
nucleic
acid
usual
low
paz
domain
exhibit
enhanc
affin
sirna
bind
recent
underlin
molecular
structur
paz
domain
across
examin
speci
mutant
gene
argonaut
famili
homolog
exhibit
sever
defect
rna
silenc
also
development
time
current
research
risc
focus
antisens
rna
guid
degrad
target
mrna
target
cleavag
occur
ninth
tenth
basepair
end
guid
antisens
rna
strand
recent
novel
protein
compris
five
repeat
nucleas
domain
known
staphylococcu
bacteria
could
purifi
associ
risc
one
nucleas
domain
fuse
tudor
domain
lead
name
tudorstaphylococc
nucleas
tudorsn
despit
conserv
mani
speci
nucleas
unlik
respons
sirnamedi
mrna
cleavag
nucleas
remain
identifi
tradit
function
gene
determin
forward
genet
experi
start
mutant
phenotyp
analysi
protein
defect
end
convers
protein
sequenc
genet
inform
mutant
phenotyp
found
patient
inherit
diseas
knockout
anim
today
gene
function
determin
revers
genet
work
opposit
direct
approach
made
possibl
huge
progress
recombin
dna
technolog
sequenc
varieti
genom
revers
genet
studi
sometim
also
refer
function
genom
meet
challeng
deciph
steadili
accumul
genet
data
function
inform
meanwhil
genet
inform
sever
organ
deciph
includ
c
elegan
melanogast
human
far
mani
method
develop
manipul
express
genet
inform
differ
level
gene
silenc
genom
level
mainli
proce
subject
isol
wildtyp
gene
vitro
mutagenesi
nucleotid
substitut
delet
insert
mutat
gene
place
back
cultur
cell
organ
interest
replac
function
gene
homolog
recombin
method
especi
exploit
silenc
gene
anim
mice
fli
mani
practic
approach
publish
includ
induc
system
enabl
spatial
tissuespecif
tempor
inhibit
gene
express
mani
method
timeconsum
labori
common
method
act
posttransl
level
deplet
protein
antibodi
mask
protein
inhibitor
block
protein
function
imit
substrat
dock
site
interact
partner
well
rnabas
aptam
intram
discoveri
rnai
posttranscript
silenc
receiv
interest
antisens
technolog
target
mrna
bound
homolog
strand
antisens
dna
modifi
dna
pna
peptid
nucleic
acid
prevent
bind
ribosom
thu
translat
mani
modif
introduc
stabil
antisens
bind
partner
system
made
way
clinic
trial
yet
antisens
technolog
never
quit
met
high
expect
wherea
rnai
catalyt
natur
seem
creat
real
hype
gener
lossoffunct
phenotyp
rnai
procedur
much
faster
straightforward
tradit
genet
approach
certainli
display
method
initi
highthroughput
experi
addit
offer
mani
advantag
method
compris
specif
effici
mrna
share
perfect
homolog
catalyt
amount
exogen
appli
dsrna
cleav
wherea
mrna
even
point
mutat
remain
unaffect
offer
simpl
handl
c
elegan
rnai
induc
simpli
inject
adult
worm
dsrna
soak
anim
dsrna
electropor
dsrna
engin
escherichia
coli
produc
appropri
dsrna
feed
bacteria
worm
soak
also
function
drosophila
cell
cultur
moreov
plant
worm
rnai
effect
diffus
across
tissu
boundari
transmit
progeni
moreov
rnai
use
simultan
silenc
sever
gene
mani
techniqu
alreadi
establish
varieti
laboratori
describ
earlier
c
elegan
rnai
alreadi
yield
impress
result
investig
function
whole
genom
includ
gene
implic
cell
divis
fat
regulatori
gene
genomewid
rnai
screen
becam
feasibl
gener
librari
bacteri
strain
produc
dsrna
individu
nematod
gene
current
librari
contain
bacteri
strain
target
approx
current
predict
gene
c
elegan
genom
lossoffunct
phenotyp
perform
system
rnai
genomewid
scale
estim
approx
review
see
ref
investig
reveal
detail
knowledg
function
target
gene
also
allow
estim
relationship
conserv
homolog
speci
like
c
elegan
drosophila
promin
organ
genomewid
function
rnai
studi
huge
number
drosophila
gene
silenc
sinc
earli
day
rnai
research
start
wingless
involv
wing
develop
recent
genomewid
rnai
screen
drosophila
schneider
cell
cell
report
studi
phenotyp
affect
cell
morpholog
moreov
rnai
use
success
dissect
mitosi
cytokinesi
unravel
cell
signal
pathway
drosophila
tissu
cultur
cell
line
drosophila
kinesin
cytoplasm
dynein
target
mitot
phenotyp
cell
analysi
function
redund
coordin
activ
rnai
subsequ
perform
simultan
target
multipl
kinesin
gene
approach
made
feasibl
rnai
techniqu
although
rnai
constitut
power
tool
studi
gene
function
plant
invertebr
applic
mammalian
system
turn
major
problem
mammal
evolv
differ
elabor
respons
dsrna
mammal
dsrna
longer
bp
mediat
interferon
respons
lead
simultan
activ
rnase
h
unspecif
degrad
mrna
transcript
protein
kinas
r
pkr
latter
phosphoryl
thu
inactiv
transcript
factor
lead
global
shutdown
protein
biosynthesi
result
apoptosi
despit
first
impress
rnai
would
work
mammalian
cell
sever
independ
group
prove
exist
mammalian
rnai
pathway
introduct
dsrna
vector
produc
dsrna
cell
line
lack
interferon
machineri
like
mice
oocyt
mice
embryon
cancer
cell
line
import
experi
establish
rnai
power
tool
mammal
perform
tuschl
cowork
use
synthet
duplex
sirna
trigger
rnai
pathway
achiev
knock
activ
transfect
endogen
gene
without
induct
interferon
respons
obvious
sirna
act
activ
intermedi
rnai
short
activ
pkr
dsrna
shorter
bp
longer
bp
ineffici
initi
rnai
well
sirna
blunt
end
short
dsrna
twonucleotid
resembl
natur
activ
product
dicer
effici
mediat
rnai
technolog
even
somat
primari
neuron
success
treat
produc
knockdown
rnai
phenotyp
investig
minim
chemic
requir
sirna
detail
mutat
scan
suggest
modif
antisens
strand
usual
reduc
activ
mispair
crucial
first
nucleotid
sens
strand
nucleotid
seem
import
riscmedi
cleavag
target
mrna
residu
essenti
sirna
direct
targetrna
cleavag
nonphosphoryl
sirna
shown
phosphoryl
vivo
cytosol
kinas
prior
entranc
rnai
pathway
shortli
discoveri
sirnamedi
rnai
mammal
empir
rule
put
design
effici
synthet
sirna
often
refer
tuschl
rule
recent
find
one
strand
sirna
enter
risc
depend
thermodynam
properti
help
design
sirna
display
even
higher
efficaci
novel
rule
design
sirna
algorithm
base
rule
consid
access
sirna
bind
site
secondari
structur
target
mrna
current
develop
refin
also
circumv
offtarget
effect
evalu
antisens
sequenc
smithwaterman
blast
search
possibl
target
date
use
sirna
becom
stateoftheart
tool
studi
gene
function
mammal
cultur
mammalian
cell
depend
type
cell
differ
chemic
physic
method
use
deliv
sirna
liposommedi
transfect
electropor
microinject
common
deliveri
method
far
regular
transfect
describ
dna
even
though
electropor
come
focu
late
transfect
still
reliabl
techniqu
especi
deliveri
adher
cell
hela
cell
mention
transfect
calcium
phosphat
effici
sirna
dna
follow
use
calcium
phosphat
polybren
variou
cation
liposom
formul
develop
increas
transfect
effici
depend
cell
type
electropor
altern
consid
nondivid
cell
cell
resist
chemic
transfect
reagent
approach
exploit
peptid
short
mpg
form
stabl
noncoval
complex
nucleic
acid
mpg
chimer
protein
compos
human
immunodefici
viru
fusion
peptid
domain
nuclear
local
sequenc
nl
larg
antigen
use
mpg
bear
mutat
nl
prevent
nuclear
entri
distribut
sirna
throughout
cytosol
approach
use
great
versatil
cellpenetr
peptid
cpp
respect
cargo
cell
type
valuabl
tool
introduct
sirna
mammalian
cell
even
fulli
grown
organ
coval
coupl
cpp
sirna
yield
socal
pepsirna
peptidecoupl
sirna
use
sirna
alreadi
help
screen
larg
number
mammalian
gene
function
unravel
molecular
basi
sever
import
biochem
process
like
signal
transduct
cell
cycl
regul
develop
cell
motil
cell
death
mani
number
target
mrna
constantli
increas
togeth
valid
vast
number
sirna
field
constantli
grow
first
genomewid
studi
alreadi
carri
publish
part
mani
gene
function
respons
embryogenesi
stem
cell
differenti
remain
determin
although
system
hardli
access
tradit
method
rnai
appear
practic
approach
alreadi
contribut
character
mani
development
gene
thu
constitut
promis
tool
elucid
mechan
involv
develop
diseas
sirnamedi
silenc
singl
isoform
shca
hela
cell
predict
crucial
role
protein
regul
cell
prolifer
likewis
sirnamedi
silenc
phosphatidylinositol
caus
drastic
decreas
growth
tissu
invas
tumor
cell
rnai
germin
vesicleintact
oocyt
found
respons
intracellular
calcium
oscil
first
step
develop
insemin
rna
interfer
also
use
silenc
sever
molecular
player
cell
cycl
dna
replic
identif
character
novel
protein
interven
embryon
neuron
develop
exampl
insight
made
possibl
new
techniqu
versatili
high
specif
minut
amount
requir
inhibit
gene
function
render
rnai
highli
promis
techniqu
combat
diseas
rna
silenc
serv
defens
retrovirus
plant
invertebr
appear
challeng
reintroduc
rnai
fight
virus
mammal
human
mani
studi
perform
treat
herp
simplex
viru
hepat
b
c
dsrnabas
approach
moreov
high
sensit
toward
point
mutat
qualifi
rnai
potenti
tool
cure
cancer
inherit
diseas
studi
ra
oncogen
possibl
target
mutat
ra
without
affect
unmut
ra
demonstr
exquisit
specif
rnai
therapeut
tool
howev
specif
could
pose
problem
therapeut
viral
infect
viral
escap
rnai
select
polioviru
mutat
target
sequenc
alreadi
demonstr
high
specif
alreadi
put
doubt
recent
find
rnai
mechan
toler
sequenc
mismatch
particularli
away
middl
cleavag
site
fact
recent
vitro
studi
show
gene
incomplet
homolog
could
partial
silenc
effect
pronounc
higher
concentr
sirna
sitespecif
deliveri
sirna
broaden
list
gene
silenc
without
induc
toxic
target
mutat
sequenc
inherit
diseas
individu
gene
mutat
need
determin
order
synthes
appropri
sirna
patientspecif
approach
would
much
costli
difficult
execut
therefor
vitro
studi
rnai
carri
date
focu
mainli
viral
infect
cancer
like
area
sirna
make
way
clinic
studi
sirna
studi
therapeut
treatment
gene
involv
autoimmuninti
neurodegen
diseas
like
alzheim
diseas
infecti
diseas
inflammatori
respons
mani
date
mani
prerequisit
still
need
fulfil
obstacl
overcom
rnai
make
way
clinic
studi
first
silenc
often
incompletea
knockdown
rather
knockoutand
residu
gene
express
might
suffici
maintain
present
phenotyp
especi
low
amount
protein
requir
fulfil
cellular
function
residu
gene
express
might
attribut
untransfect
cell
low
affin
select
sirna
toward
target
mrna
rapidli
divid
transform
cell
silenc
effect
rather
shortliv
transfect
sirna
rapidli
dilut
obstacl
clinic
applic
rnai
often
insuffici
transfect
effici
limit
persist
transient
rnai
phenotyp
obtain
persist
rna
silenc
cell
organ
differ
plasmid
viral
vector
develop
express
short
hairpin
rna
control
rna
polymeras
iii
pol
iii
rnase
polymeras
ii
pol
ii
promot
upon
transfect
vector
sirna
constitut
endogen
express
current
use
vector
employ
short
hairpin
rna
shrna
express
cassett
resembl
premirna
undergo
process
dicer
design
accord
rule
synthet
sirnaa
match
perfectli
target
mrna
thu
trigger
degrad
achiev
constitut
silenc
effect
shrna
transcript
must
transloc
nucleu
cytoplasm
recogn
dicer
transfer
risc
sirna
hairpinexpress
plasmid
specif
suppress
gene
express
transient
persist
manner
depend
design
thu
lossoffunct
phenotyp
gener
longer
period
time
requir
fulli
deplet
cytosol
residu
target
protein
potenc
shrna
trigger
rnai
mammalian
cell
compar
synthet
sirna
duplex
mani
case
strong
rna
polymeras
iii
promot
human
murin
employ
control
express
shrna
vivo
rna
polymeras
iii
respons
transcript
limit
number
gene
includ
rna
trna
rna
snrna
number
small
stabl
rna
involv
rna
process
assum
long
dsrna
effect
trigger
effici
process
sirna
result
highli
cooper
bind
long
dsrna
strand
addit
featur
cleavag
dicer
incorpor
nascent
sirna
transfer
protein
complex
despit
concern
discuss
within
field
rnai
recent
shown
endogen
express
long
hairpin
dsrna
lhrna
capabl
induc
rnai
mammalian
somat
cell
includ
human
primari
fibroblast
melanocyt
hela
cell
even
whole
mice
taken
cell
tissu
express
vector
requir
classic
method
like
electropor
microinject
liposom
transfer
dna
precursor
vector
cell
line
easi
transfect
recombin
cell
clone
perman
express
rnai
phenotyp
select
howev
without
cell
divis
shrna
dna
construct
enter
nucleu
requir
dna
transcript
passiv
resid
cytosol
therefor
nondivid
cell
suscept
transfect
primari
cell
stem
cell
number
import
cell
type
resist
introduct
sirna
shrna
lack
appropri
deliveri
system
even
problemat
deliveri
sirna
directli
entir
vertebr
anim
high
toxic
cation
transfect
reagent
prohibit
wholebodi
applic
sirna
aid
liposom
chemic
approach
wherea
physic
techniqu
like
hydrodynam
transfect
method
shown
success
mice
nake
sirna
appli
mice
via
tailvein
inject
caus
knock
report
gene
liver
kidney
spleen
lung
pancrea
yet
effect
rather
shortliv
last
day
organ
cell
type
access
anoth
method
circumv
mani
difficulti
make
use
viral
vector
infect
cell
dsrna
express
construct
retrovir
vector
like
adenovir
vector
predominantli
lentivir
vector
current
use
viral
deliveri
system
approach
almost
everi
cell
tissu
includ
stem
cell
neuron
treat
shrnaproduc
vector
advantag
lentivir
approach
lie
possibl
systemat
test
gene
function
context
entir
organ
anim
model
gener
straigthforward
manner
determin
gene
import
function
differ
tissu
organ
might
effect
therapeut
target
diseas
even
though
tuschl
cowork
observ
sirna
shorter
nt
trigger
interferon
respons
recent
report
concern
nonspecif
effect
induc
endogen
express
shrna
transfect
sirna
transcript
shrna
lead
interferon
ifn
mediat
activ
jakstat
pathway
global
upregul
interferonstimul
gene
within
nucleu
found
dsrnadepend
protein
kinas
pkr
activ
intracellular
presenc
sirna
trigger
upregul
ifn
possibl
cellular
signal
molecul
compar
studi
interferon
induct
sirna
shrna
counterpart
show
significantli
stronger
interferon
respons
applic
shrna
side
effect
need
studi
close
settl
current
controversi
kept
mind
almost
plasmid
vector
induc
interferon
respons
upon
transfect
independ
type
insert
bear
therapeut
strategi
sirna
base
silenc
diseaserel
gene
without
alter
express
essenti
gene
begin
rnai
research
assum
target
mrna
homolog
sirna
dsrna
influenc
express
mrna
date
know
singl
knockdown
gene
induc
varieti
chang
overal
gene
express
long
distinguish
chang
result
silenc
singl
gene
caus
unspecif
effect
approach
resembl
benefit
drawback
alreadi
describ
gene
therapi
first
approach
aim
use
rnai
therapeut
applic
silenc
viral
gene
regard
number
outbreak
peopl
infect
worldwid
sever
group
virus
current
recogn
import
human
pathogen
among
aquir
immunodefici
syndrom
aid
hepat
influenza
viral
diseas
global
dimens
bring
along
high
morbid
mortal
influenza
even
occur
annual
epidem
pandem
infrequ
occurr
high
attack
rate
although
rnai
ancient
antivir
defens
plant
invertebr
play
import
role
mammal
nevertheless
rnai
machineri
present
mammal
might
exploit
inhibit
viral
infect
upon
trigger
sirna
far
mani
group
success
activ
pathway
viral
target
divers
replic
strategi
includ
hiv
hepat
b
c
hbv
hcv
human
papilloma
viru
hpv
polio
viru
herp
viru
human
tcell
leukemia
respiratori
syncyti
viru
influenza
epsteinbarr
viru
final
corona
virus
sar
begin
mostli
gene
respect
viru
target
bitko
barik
first
observ
specif
antivir
effect
sirna
respiratori
syncyti
viru
shortli
effect
report
polioviru
infect
human
cell
use
sirna
direct
differ
region
genom
includ
long
termin
repeat
gene
encod
highli
conserv
gene
vif
nef
sirnatr
cell
particularli
immun
subsequ
infect
shortterm
experi
novina
cowork
use
contrari
approach
notabl
reduc
abil
enter
cell
target
receptor
respons
entri
host
cell
indic
viral
infect
also
stop
host
gene
involv
viral
life
cycl
target
studi
clearli
show
rnai
hold
promis
becom
effici
tool
treatment
viral
infecti
diseas
human
howev
rnai
make
way
therapeut
applic
appropri
sirna
deliveri
system
requir
guid
activ
speci
target
organ
interestingli
sirna
deliveri
mice
hydrodynam
inject
tail
vein
led
gene
downregul
major
liver
cell
howev
techniqu
requir
high
pressur
larg
volum
sirna
solut
make
inappropri
applic
human
hand
coinject
luciferasetarget
sirna
plasmidluciferas
tail
vein
mice
gene
silenc
observ
sever
organ
includ
liver
spleen
kidney
lung
mice
also
heal
fasinduc
fulmin
hepat
inject
appropri
sirna
strike
result
obtain
hbv
rnai
could
inhibit
product
hbv
replic
intermedi
cell
cultur
immunocompet
immunodefici
mice
transfect
hbv
plasmid
upon
sirna
treatment
substanti
reduc
level
hbv
rna
replic
hbv
genom
found
mous
liver
studi
target
gene
rel
conserv
differ
viral
strain
exhibit
low
mutat
activ
found
gene
essenti
replic
likewis
host
gene
requir
viral
entri
play
essenti
role
viral
life
cycl
also
potenti
target
spite
great
excit
creat
studi
kept
mind
experi
perform
cell
cultur
model
anim
use
laboratori
strain
virus
well
character
recent
studi
indic
therapeut
treatment
viral
infect
stand
expect
long
term
sirna
direct
highli
conserv
nef
gene
sirnanef
confer
resist
replic
howev
inhibit
replic
complet
sever
week
cultur
escap
variant
appear
longer
inhibit
sirnanef
nucleotid
substitut
delet
nef
gene
alter
homolog
sirnanef
sequenc
minim
risk
viral
escap
sever
viral
host
gene
must
target
simultan
infecti
diseas
spread
parasit
also
subject
therapeut
rnai
approach
protozoan
parasit
pathogen
fungi
often
resist
manipul
standard
molecular
genet
approach
discoveri
rnai
trypanosoma
brucei
provid
conveni
method
gener
knockout
phenotyp
parasit
erythrocyteinfect
stage
malaria
parasit
plasmodium
falciparum
success
treat
dsrna
encod
dihydroorot
dehydrogenas
dhodh
applic
rnai
fight
diseas
reach
limit
come
bacteri
infect
prokaryot
amen
silenc
sirna
yet
manipul
host
gene
involv
bacteri
invas
immun
respons
might
help
immun
cell
tissu
bacteri
infect
recent
discoveri
dna
rna
edit
role
prokaryot
pin
domain
strikingli
numer
thermophil
organ
mycobacterium
tuberculosi
support
idea
similar
eukaryot
counterpart
bacteri
pin
domain
particip
relat
rna
silenc
mechan
nonsensemedi
rna
degrad
initi
flood
mainli
descript
report
effect
bacteri
infect
transcriptom
proteom
studi
becom
refin
approach
shed
light
role
pathogenhost
interact
eventu
target
rnai
first
rnai
experi
target
proinflammatori
cytokin
tumor
necrosi
factor
success
reduc
sepsi
trigger
lipopolysaccharid
lp
mice
intervent
peroxisom
proliferationactiv
receptor
ppar
antiinflammatori
mechan
treatment
chronic
inflamm
one
mani
possibl
sever
vitro
studi
alreadi
demonstr
potenti
use
rnai
cancer
treatment
cancer
cell
usual
differ
normal
cell
uncontrol
growth
abil
escap
program
cell
death
apoptosi
nutrit
suppli
assembl
network
blood
vessel
around
tumor
evad
chemotherapi
might
chang
surfac
composit
therefor
target
possibl
rnai
treatment
gene
either
involv
cell
divis
prolifer
growth
factor
tumor
suppressor
gene
transcript
factor
apoptosi
inhibitor
protooncogen
take
part
mani
regulatori
event
signal
cascad
ra
well
viral
oncogen
human
papilloma
viru
hpv
impair
apoptosi
signal
associ
tumor
develop
confer
resist
chemotherapi
apoptosi
trigger
death
receptor
pathway
mani
tumor
antiapoptot
protooncogen
overexpress
inhibit
express
potenti
facilit
tumor
necrosi
factorrel
apoptosi
induc
ligand
trail
induc
apoptosi
multidrug
resist
protein
pump
chemotherapeut
drug
tumor
factor
stimul
angiogenesi
connect
tumor
nutrit
resourc
also
potenti
rnai
target
select
target
list
tabl
wellknown
target
bcrabl
mutat
ra
human
papilloma
viru
hpv
protooncogen
like
cmyb
bcell
lymphoma
protein
target
rnai
promis
exampl
apoptosi
trigger
tumor
cell
import
regul
program
cell
death
overexpress
implic
pathogenesi
lymphoma
resist
chemotherapi
least
vitro
might
also
relat
overexpress
compar
studi
singl
sirna
combin
sirna
success
transfect
hela
cell
lung
adenocarcinoma
cell
hepatoma
cell
ovarian
carcinoma
cell
melanoma
cell
cation
lipid
complex
downregul
protooncogen
apopotosi
inhibitor
pkcalpha
hra
vegf
effect
suppress
prolifer
cancer
cell
differ
extent
lead
conclus
chemic
synthes
vectordriven
sirna
inhibit
growth
prolifer
cancer
cell
ra
power
regul
sever
interconnect
receptorsign
pathway
mutat
form
constitut
activ
act
oncogen
process
thought
contribut
malign
transform
mani
cell
type
make
element
signal
pathway
attract
target
inhibit
rnai
previou
attempt
silenc
ra
oncogen
phosphorothio
oligonucleotid
succeed
stabil
diseas
silenc
crucial
effector
ra
signal
like
rafc
kinas
oligonucleotid
show
low
moder
effect
vitro
vivo
tumorxenograft
model
wherea
treatment
sirna
specif
silenc
express
oncogen
kra
tumor
cell
tumor
suppressor
often
genet
alter
bcrabl
howev
target
abl
sequenc
bcrabl
rnai
might
therapi
chronic
myeloid
leukemia
select
commonli
studi
target
gene
supplement
tabl
howev
major
drawback
applic
therapi
far
remain
issu
deliveri
despit
specif
target
protooncogen
leav
express
wildtyp
gene
unalt
mani
target
protein
also
play
role
nonprolifer
cell
healthi
organ
downregul
target
requir
method
allow
direct
deliveri
tumor
without
affect
cell
deliveri
agent
need
tailormad
tumor
differ
organ
tumor
deriv
far
mani
approach
made
either
modifi
dendrim
liposom
modifi
lentivirus
adenovirus
date
reliabl
result
obtain
apart
cancer
infecti
diseas
cardiovascular
diseas
caus
highest
mortal
western
world
develop
strategi
prevent
diseas
therefor
high
prioriti
rnai
current
use
elucid
underli
mechan
cardiovascular
diseas
howev
therapi
still
way
reach
likewis
number
patient
neurodegen
diseas
alzheim
diseas
parkinson
diseas
amyotroph
later
sclerosi
grow
increas
lifespan
human
mani
studi
support
therapeut
potenti
rnaibas
method
treatment
diseas
like
myotroph
later
sclerosi
search
possibl
candid
gene
respons
alzheim
diseas
parkinson
diseas
proceed
rapid
pace
howev
deliveri
even
problem
trespass
bloodbrain
barrier
involv
neuron
cultur
sensit
transfect
effici
convent
method
poor
vivo
bloodbrain
barrier
prevent
uptak
substanc
remain
vascular
system
except
small
less
da
lipidsolubl
molecul
consequ
reduc
bioavail
intraven
appli
oligonucleotid
brain
virtual
zero
even
though
alreadi
possibl
treat
primari
neuron
neuron
cell
line
sirna
vivo
studi
mice
begin
mani
method
publish
far
bear
drawback
nonetheless
could
shown
adenovir
vector
success
pass
bloodbrain
barrier
intraven
applic
express
brain
other
inject
sirna
express
adenovir
vector
directli
brain
observ
decent
rnai
phenotyp
time
biologist
face
enorm
challeng
decrypt
genet
messag
encod
whole
genom
rnai
techniqu
repres
preciou
tool
use
either
synthet
stabli
express
sirna
greatli
facilit
acceler
genomewid
function
screen
model
organ
navig
within
decrypt
genet
landscap
also
sirnamedi
gene
silenc
one
standard
method
studi
specif
role
protein
integr
cellular
pathway
howev
although
rnai
turn
effici
approach
downregul
viral
activ
cultur
mammalian
cell
applic
therapeut
approach
human
feasibl
risk
unspecif
respons
side
effect
elimin
demand
better
understand
rnairel
process
particularli
correl
structur
featur
natur
mirna
strictli
specif
mode
action
turn
provid
basic
refer
design
sirna
use
therapeut
purpos
last
appropri
system
sirna
deliveri
vivo
still
need
develop
rnai
one
largest
grow
field
biolog
pharmacolog
medicin
even
chemistri
although
mechan
dsrna
modul
gene
express
clarifi
develop
novel
approach
cure
diseas
relat
gene
express
proceed
point
vivo
experi
anim
model
afoot
recent
develop
leukemia
cell
cancer
cell
resist
wellknown
smallmolecul
inhibitor
call
novel
treatment
even
though
cell
might
abl
evolv
mutat
protein
evad
smallmolecul
protein
inhibitor
happen
encod
mrna
degrad
rnai
might
held
mani
promis
yet
experi
patient
without
doubt
time
celebr
signific
achiev
clinic
trial
forthcom
soon
